MTBC Signs Top Pharmaceutical Manufacturer to its Physician Vaccine Discount Program
October 26 2018 - 8:15AM
MTBC (Nasdaq: MTBC) (Nasdaq: MTBCP), a leading provider of
proprietary, cloud-based healthcare IT and practice management
solutions today announced that it has entered into a new group
purchasing contract with one of the world’s top five pharmaceutical
manufacturers. This new affiliation will allow the members of
MTBC’s group purchasing organization (GPO) to purchase critical
vaccines for their practices at a negotiated discount.
“We’re pleased to now offer our clients vaccine
discounts with 3 of the world’s top 5 pharmaceutical
manufacturers,” said Al Nardi, VP Strategic Initiatives for
MTBC. Nardi added, “We’re extending these significant
discounts at no cost to our clients, and encouraging all other U.S.
based physicians who purchase vaccines to join the MTBC family so
they can start saving on the cost of the very same vaccines they
already purchase.”
This new group purchasing contract has expanded
the offering of vaccines to MTBC’s clients at the special
discounted rate that MTBC has negotiated with the
manufacturer. As part of a recent acquisition, MTBC acquired
the GPO, which enables thousands of physician members to purchase
vaccines from leading pharmaceutical companies at discounted rates.
The GPO is an essential component of MTBC’s
initiative to improve healthcare performance improvement through
its full suite of services including revenue cycle management,
practice management, and innovative healthcare IT offerings.
“We continually look for new and creative ways to address the needs
of our clients and increase the value we can offer them,” stated
Nardi.
Additional information regarding MTBC’s GPO can
be found at www.mtbc.com/gpo.
About MTBC
MTBC is a healthcare information technology
company that provides a fully integrated suite of proprietary
web-based solutions, together with related business services, to
healthcare providers. Our integrated Software-as-a-Service (or
SaaS) platform helps our customers increase revenues, streamline
workflows and make better business and clinical decisions, while
reducing administrative burdens and operating costs. MTBC's common
stock trades on the NASDAQ Capital Market under the ticker symbol
"MTBC," and its Series A Preferred Stock trades on the NASDAQ
Capital Market under the ticker symbol "MTBCP." For additional
information, please visit our website at www.mtbc.com.
Forward-Looking Statements
This release contains various forward-looking
statements within the meaning of the federal securities laws. These
statements relate to anticipated future events, future results of
operations or future financial performance. In some cases, you can
identify forward-looking statements by terminology such as "may,"
"might," "will," "should," "intends," "expects," "plans," "goals,"
"projects," "anticipates," "believes," "estimates," "predicts,"
"potential," or "continue" or the negative of these terms or other
comparable terminology.
Our operations involve risks and uncertainties,
many of which are outside our control, and any one of which, or a
combination of which, could materially affect our results of
operations and whether the forward-looking statements ultimately
prove to be correct. Forward-looking statements in this release
include, without limitation, statements reflecting management's
expectations for future sales, partnerships, expected growth, and
increased sales and marketing. Nothing discussed in this
release is anticipated to have a material impact on the Company’s
current year financial statements.
These forward-looking statements are only
predictions, are uncertain and involve substantial known and
unknown risks, uncertainties and other factors which may cause our
(or our industry’s) actual results, levels of activity or
performance to be materially different from any future results,
levels of activity or performance expressed or implied by these
forward-looking statements. New risks and uncertainties emerge from
time to time, and it is not possible for us to predict all of the
risks and uncertainties that could have an impact on the
forward-looking statements, including without limitation, risks and
uncertainties relating to: the Company's ability to manage growth;
the parties’ ability to cross-market and cross-sell their
solutions; the longevity of the partnership discussed in this
release; and other important risks and uncertainties referenced and
discussed under the heading titled “Risk Factors” in the Company's
filings with the Securities and Exchange Commission.
The statements in this press release are made as
of the date hereof, even if subsequently made available by the
Company on its website or otherwise. The Company does not assume
any obligations to update the forward-looking statements provided
to reflect events that occur or circumstances that exist after the
date on which they were made.
Follow MTBC on Twitter, LinkedIn and
Facebook.
SOURCE MTBC
Company Contact:Rachel GrossingerMarketing
Managerrgrossinger@mtbc.com732-873-5133
Investor Contact:Bill KornChief Financial
Officerbkorn@mtbc.com (732) 873-5133
CareCloud (NASDAQ:MTBC)
Historical Stock Chart
From Apr 2024 to May 2024
CareCloud (NASDAQ:MTBC)
Historical Stock Chart
From May 2023 to May 2024